Intestinal permeability evaluation in patients with chronic Chagas heart failure

被引:1
作者
Rodrigues, Angela Braga [1 ,5 ]
Torres, Henrique Oswaldo da Gama [2 ]
Pereira Nunes, Maria do Carmo [1 ,2 ]
Silva Gomes, Juliana de Assis [3 ]
Rodrigues, Aline Braga [4 ]
Pinho, Laura Lopes Nogueira [2 ]
Rocha, Manoel Otavioda da Costa [1 ,2 ]
Botoni, Fernando Antonio [1 ,2 ]
机构
[1] Univ Fed Minas Gerais, Sch Med, Postgrad Course Infect Dis & Trop Med, Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Sch Med, Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, Belo Horizonte, MG, Brazil
[4] Hosp Felicio Rocho, Dept Cardiol, Belo Horizonte, MG, Brazil
[5] Univ Fed Minas Gerais, Sch Med, Postgrad Course Infect Dis & Trop Med, Ave Alfredo Balena,190 Campus Saude, BR-30130100 Belo Horizonte, Brazil
来源
ESC HEART FAILURE | 2023年 / 10卷 / 02期
关键词
Chagasic heart failure; Intestinal dysfunction; Intestinal permeability; BIOMARKERS; MANAGEMENT; MORTALITY; BARRIER; DISEASE; GUT;
D O I
10.1002/ehf2.14156
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsWe analysed intestinal permeability in patients with chronic Chagas cardiomyopathy (CCC) and evaluated its association with clinical manifestations, haemodynamic parameters measured by echocardiogram, and disease outcome. Intestinal permeability was compared between CCC patients and a group of healthy controls. BackgroundIntestinal dysfunction may contribute to a more severe disease presentation with worse outcome in patients with CCC and heart failure. MethodsFifty patients with CCC and left ventricular ejection fraction (LVEF) of less than 55% were prospectively selected and followed for a mean period of 18 +/- 8 months. A group of 27 healthy volunteers were also investigated. One patient was excluded from the analysis since he died before completing the intestinal permeability test.Intestinal permeability was evaluated with the sugar probe drink test. It consists in the urinary recovery of previously ingested sugar probes: mannitol, a monosaccharide, and lactulose, a disaccharide. ResultsPatient's mean age was 53.4 +/- 10.4 years, and 31(63%) were male. Differential urinary excretion of lactulose/mannitol ratio did not differ significantly between healthy controls and CCC patients, regardless of clinical signs of venous congestion, haemodynamic parameters, and severity of presentation and outcome. ConclusionsThe present study could not show a disturbance of the intestinal barrier in CCC patients with LVEF <55%, measured by lactulose/mannitol urinary excretion ratio. Further investigations are needed to verify if in patients with LVEF <40% intestinal permeability is increased.
引用
收藏
页码:1250 / 1257
页数:8
相关论文
共 24 条
[1]  
[Anonymous], 2015, Wkly Epidemiol Rec, V90, P33
[2]   Collagen accumulation and dysfunctional mucosal barrier of the small intestine in patients with chronic heart failure [J].
Arutyunov, Gregory P. ;
Kostyukevich, Olga I. ;
Serov, Roman A. ;
Rylova, Natalya V. ;
Bylova, Nadezda A. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 125 (02) :240-245
[3]   Chagas Cardiomyopathy Clinical Presentation and Management in the Americas [J].
Benziger, Catherine Pastorius ;
Lopes do Carmo, Gabriel Assis ;
Pinho Ribeiro, Antonio Luiz .
CARDIOLOGY CLINICS, 2017, 35 (01) :31-+
[4]   Intestinal permeability - a new target for disease prevention and therapy [J].
Bischoff, Stephan C. ;
Barbara, Giovanni ;
Buurman, Wim ;
Ockhuizen, Theo ;
Schulzke, Joerg-Dieter ;
Serino, Matteo ;
Tilg, Herbert ;
Watson, Alastair ;
Wells, Jerry M. .
BMC GASTROENTEROLOGY, 2014, 14
[5]   INTESTINAL PERMEABILITY - AN OVERVIEW [J].
BJARNASON, I ;
MACPHERSON, A ;
HOLLANDER, D .
GASTROENTEROLOGY, 1995, 108 (05) :1566-1581
[6]   A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy [J].
Botoni, Fernando A. ;
Poole-Wilson, Philip A. ;
Ribeiro, Antonio L. P. ;
Okonko, Darlington O. ;
Oliveira, Brilullo M. R. ;
Pinto, Airandes S. ;
Teixeira, Mauro M. ;
Teixeira, Antonio L., Jr. ;
Reis, Adelina M. ;
Dantas, Jackellyne B. P. ;
Ferreira, Cid. S. ;
Tavares, Wilson C., Jr. .
AMERICAN HEART JOURNAL, 2007, 153 (04) :544.e1-544.e8
[7]   Biomarkers in heart failure [J].
Braunwald, Eugene .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (20) :2148-2159
[8]   Intestinal barrier function in health and gastrointestinal disease [J].
Camilleri, M. ;
Madsen, K. ;
Spiller, R. ;
Van Meerveld, B. G. ;
Verne, G. N. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 (06) :503-512
[9]   Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease [J].
Keating, S. M. ;
Deng, X. ;
Fernandes, F. ;
Cunha-Neto, E. ;
Ribeiro, A. L. ;
Adesina, B. ;
Beyer, A. I. ;
Contestable, P. ;
Custer, B. ;
Busch, M. P. ;
Sabino, E. C. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 199 :451-459
[10]   The importance of the gastrointestinal system in the pathogenesis of heart failure [J].
Krack, A ;
Sharma, R ;
Figulla, HR ;
Anker, SD .
EUROPEAN HEART JOURNAL, 2005, 26 (22) :2368-2374